| Particulars (in ₹ Cr.) | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Revenue | 2,542.16 | 2,565.34 | 1,935.76 | 2,196.38 | 1,555.05 |
| Total Expenses | 2,200.36 | 2,025.24 | 1,645.04 | 1,673.91 | 1,171.63 |
| Profit Before Tax | 340.76 | 541.09 | 290.75 | 522.46 | 383.42 |
| Profit After Tax | 331.97 | 357.69 | 195.87 | 353.29 | 252.79 |
| Operating Profit After Depreciation | 413.76 | 593.37 | 364.21 | 587.98 | 427.69 |
| Particulars (in ₹ Cr.) | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Fixed Assets | 2,117.19 | 2,238.02 | 1,766.64 | 1,804.05 | 1,067.83 |
| Total Non Current Assets | 2,678.61 | 2,377.20 | 2,292.41 | 2,012.74 | 1,676.72 |
| Total Current Assets | 826.69 | 775.24 | 501.93 | 419.50 | 446.94 |
| Total Assets | 3,505.30 | 3,152.44 | 2,794.34 | 2,432.24 | 2,123.67 |
| Total Shareholder's Fund | 2,221.43 | 1,904.53 | 1,254.10 | 1,069.10 | 725.97 |
| Particulars (in ₹ Cr.) | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 435.53 | 440.56 | 397.64 | 626.16 | 283.82 |
| Net Cash Used In Investing Activities | -354.67 | -261.56 | -401.10 | -437.22 | -454.63 |
| Net Cash Used In Financing Activities | -94.48 | -163.54 | -7.60 | -199.79 | 195.22 |
| Particulars (in ₹ Cr.) | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Revenue | 2,542.16 | 2,565.34 | 1,935.71 | 2,196.38 | 1,555.05 |
| Total Expenses | 2,200.36 | 2,025.24 | 1,645.04 | 1,673.86 | 1,171.63 |
| Profit Before Tax | 341.80 | 540.10 | 290.67 | 522.53 | 383.42 |
| Profit After Tax | 333.01 | 356.70 | 195.79 | 353.36 | 252.79 |
| Operating Profit After Depreciation | 413.76 | 593.37 | 364.16 | 588.03 | 427.69 |
| Particulars (in ₹ Cr.) | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Fixed Assets | 2,117.19 | 2,238.02 | 1,766.64 | 1,804.05 | 1,067.83 |
| Total Non Current Assets | 2,678.65 | 2,376.20 | 2,292.40 | 2,012.80 | 1,676.77 |
| Total Current Assets | 826.69 | 775.24 | 501.93 | 419.45 | 446.89 |
| Total Assets | 3,505.34 | 3,151.44 | 2,794.33 | 2,432.25 | 2,123.67 |
| Total Shareholder's Fund | 2,221.47 | 1,903.53 | 1,254.09 | 1,069.17 | 725.97 |
| Particulars (in ₹ Cr.) | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 435.53 | 440.56 | 397.69 | 626.16 | 283.82 |
| Net Cash Used In Investing Activities | -354.67 | -261.56 | -401.10 | -437.22 | -454.68 |
| Net Cash Used In Financing Activities | -94.48 | -163.54 | -7.60 | -199.79 | 195.22 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 736.16 | 597.12 | 587.36 | 606.54 | 627.63 |
| Total Expenses | 568.56 | 494.42 | 455.30 | 443.15 | 454.25 |
| Profit Before Tax | 109.54 | 54.56 | 69.65 | 107.01 | 131.33 |
| Profit After Tax | 80.95 | 39.11 | 51.22 | 160.69 | 86.89 |
| Operating Profit after Depreciation | 167.03 | 108.26 | 133.80 | 171.92 | 177.05 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 736.16 | 597.12 | 587.36 | 606.54 | 627.63 |
| Total Expenses | 567.58 | 494.38 | 455 | 443.15 | 454.25 |
| Profit Before Tax | 110.52 | 54.60 | 69.95 | 106.73 | 131.06 |
| Profit After Tax | 81.93 | 39.15 | 51.52 | 160.41 | 86.62 |
| Operating Profit after Depreciation | 168.01 | 108.30 | 134.10 | 171.64 | 176.78 |
₹5.0/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Pidilite Industries Ltd | ₹1,498.80 | ₹1,52,544.17 |
| SRF Ltd | ₹2,658.95 | ₹78,817.88 |
| Linde India Ltd | ₹6,709.95 | ₹57,222.45 |
| Gujarat Fluorochemicals Ltd | ₹3,680.65 | ₹40,431.94 |
| Navin Fluorine International Ltd | ₹7,186.40 | ₹36,863.93 |
| Fund Name | AUM |
|---|---|
| HSBC Focused Fund | 1.73% |
| Bandhan Business Cycle Fund | 0.82% |
| HSBC Business Cycles Fund | 0.78% |
| Bandhan Small Cap Fund | 0.50% |
| HSBC Value Fund | 0.39% |
Epigral added 1.46% to Rs 1147 after the company said that Crisil Ratings has reaffirmed its 'Crisil AA/Stable/Crisil A1+' ratings on the bank facilities of the company.
04 Jun 2026, 12:19 pm
On 8 June 2026
15 May 2026, 01:01 pm
Epigral surged 7.79% to Rs 1,297 after the company reported a sharp sequential improvement in performance for the March quarter.
04 May 2026, 10:29 am
Of Rs 5 per share
02 May 2026, 04:26 pm
On 2 May 2026
27 Apr 2026, 04:25 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.